Welcome back,

CONFERENCE UPDATE

ESMO 2024

European Society for Medical Oncology Congress 2024

September 13-17, 2024 |

Barcelona, Spain

2024

Development of a TR-TRM model as a risk prediction tool for severe toxicities in elderly cancer patients on systemic treatment
ONCOLOGY

21 Feb 2025
Enzalutamide + Ra223 shows rPFS benefits in asymptomatic or mildly symptomatic patients with bone-metastatic mCRPC: Results from the PEACE-3 trial
21 Feb 2025
Endocrine therapy interruption in HR-positive breast cancer enables feasible and safe breastfeeding after conception

ONCOLOGY
|
OBSTETRICS & GYNECOLOGY

12 Dec 2024
First-line lorlatinib shows 5-year benefits in Asian patients with ALK+ NSCLC: Post-hoc analysis from the CROWN trial
20 Feb 2024

eaa0190a-4510-467f-900f-c94c7b668484